Indeed, we observed an increased DC activation, as measured by the upregulation of the co‐stimulatory molecule CD86, post immunisation with ACM‐Trp2 + free CpG, aiding the efficient priming of Trp2‐tumour‐specific T cells. Here, CD86 is linked to neoplasm.